The M949_1556 gene plays a role on the bacterial antigenicity and pathogenicity of Riemerella anatipestifer

https://doi.org/10.1016/j.vetmic.2015.03.003Get rights and content

Highlights

  • M949_1556 gene inactivated RA mutant CH3ΔM949_1556 was identified.

  • The mutant lost reactivity to the anti-LPS MAb in an indirect ELISA.

  • The virulence of the mutant was attenuated more than 50 times.

  • The mutant showed much higher susceptibility to complement-dependent killing.

  • The mutant provided a broad cross-protection among RA serotypes 1, 2 and 10 strains.

Abstract

Riemerella anatipestifer is one of the most economically important pathogens of farm ducks worldwide. However, the molecular mechanisms regarding its antigenicity and pathogenicity are poorly understood. We previously constructed a library of random Tn4351 transposon mutants using R. anatipestifer strain CH3. In this study, M949_1556 gene inactivated mutant strain CH3ΔM949_1556 was identified by screening of the library using monoclonal antibody against R. anatipestifer serotype 1 lipopolysaccharide (LPS) (anti-LPS MAb) followed by sequence analysis. The mutant strain presented no reactivity to the anti-LPS MAb in an indirect ELISA. Animal studies showed that the median lethal dose (LD50) of CH3ΔM949_1556 was >1010 colony forming units (CFU), which was attenuated more than 50 times, compared with that of wild-type strain CH3 (LD50 = 2 × 108 CFU). The bacterial loads in the blood of CH3ΔM949_1556 infected ducks were significantly decreased, compared with those of CH3-infected ducks. In addition, CH3ΔM949_1556 presented significant, higher susceptibility to complement-dependent killing than CH3 did in vitro. Furthermore, CH3ΔM949_1556 showed increased bacterial adhesion and invasion capacities to Vero cells. Immunization with CH3ΔM949_1556-inactived vaccine was effective in protecting the ducks from challenge with R. anatipestifer serotype 1 strain WJ4, serotype 2 strain Yb2 and serotype 10 strain HXb2, suggesting that the mutant strain CH3ΔM949_1556 could provide a broad cross-protection among R. anatipestifer serotypes 1, 2 and 10 strains. Our results demonstrated that the M949_1556 gene plays a role on the bacterial antigenicity and pathogenicity of R. anatipestifer.

Introduction

Riemerella anatipestifer is a Gram-negative, non-motile, non-spore-forming, rod-shaped bacterium, and it belongs to the Flavobacteriaceae family in rRNA superfamily V (Segers et al., 1993). R. anatipestifer infection primarily causes disease in domestic ducks, and accounts for major economic losses to the industry (Sandhu and Rimler, 1997). A total of 21 serotypes of R. anatipestifer have been identified with no significant cross-protection reported (Pathanasophon et al., 1995, Pathanasophon et al., 2002). Serotypes 1, 2, and 10 are responsible for most of the major R. anatipestifer outbreaks in China (Hu et al., 2010). The chaperonin GroEL was the first reported protein providing a cross-protection among R. anatipestifer serotypes 1, 2 and 10 (Han et al., 2012), although the protection rate is not as high as that of inactivated bacterin (Liu et al., 2013). The mixture of recombinant Riean_1750 and Riean_1752, two proteins identified from R. anatipestifer cultured in iron restricted medium, provided 100% protection against challenge with R. anatipestifer, but no cross-protection was shown (Yang et al., 2013). On the other hand, several genes have been identified as virulence factors of R. anatipestifer strains, including VapD, CAMP cohemolysin and outer membrane protein A (OmpA) (Chang et al., 1998).

Our previous study has constructed a random Tn4351 transposon insertion library using R. anatipestifer strain CH3 and identified 33 biofilm-forming associated genes from the library in the genome wide (Hu et al., 2010). In this study, we screened the library using monoclonal antibody against R. anatipestifer serotype 1 lipopolysaccharide (LPS) (anti-LPS MAb) and one mutant which lost the reactivity with anti-LPS MAb was obtained. Sequence analysis showed that the M949_1556 gene was inactivated in the mutant strain, which was named as CH3ΔM949_1556. Furthermore, the bacterial antigenicity and pathogenicity of CH3ΔM949_1556 were characterized.

Section snippets

Animals

One-day old Cherry Valley ducks were obtained from ZhuangHang Duck Farm (Shanghai, China) and kept under controlled temperature (28–30 °C). The ducks were housed in cages and a 12-h light/dark cycle with free access to food and water was provided during the study. Animal experiments were carried out in accordance with the Institutional Animal Care and Use Committee (IACUC) guidelines set by Shanghai Veterinary Research Institute, the Chinese Academy of Agricultural Sciences (CAAS). This animal

Identification of the mutant strain CH3ΔM949_1556

A stable hybridoma cell clone 8A9 producing monoclonal antibody against R. anatipestifer serotype 1 strain (anti-LPS MAb) was established. MAb titer in the ascite was assessed over 1:102,400 by ELISA. The mutant strain CH3ΔM949_1556 was obtained by screening the transposon library for the defective reactivity with anti-LPS MAb using an indirect ELISA. Single Tn4351 insertion in the CH3ΔM949_1556 chromosome was confirmed by Southern blot (Fig. 1A). Sequencing of the cloned DNA fragment revealed

Discussion

In this study, CH3ΔM949_1556 mutant was identified by screening the library of random Tn4351 transposon mutants using anti-LPS MAb. The mutant does not bind to anti-LPS MAb in an indirect ELISA. Further studies indicated that the mutant strain showed no significant difference in growth rate but obvious deficient in ladder-like binding pattern of CH3 LPS to anti-CH3 rabbit serum and significant attenuated virulence in duck model, compared to its wild-type strain CH3, indicating deletion of

Acknowledgement

This work was supported by the National Natural Science Foundation of China (31272591).

References (38)

  • F. Urbina et al.

    Structural elucidation of the O-antigenic polysaccharide from the enteroaggregative Escherichia coli strain 180/C3 and its immunochemical relationship with E. coli O5 and O65

    Carbohydr. Res.

    (2005)
  • M.V. Zaccheus et al.

    Structural studies of the O-antigen polysaccharide from Escherichia coli TD2158 having O18 serogroup specificity and aspects of its interaction with the tailspike endoglycosidase of the infecting bacteriophage HK620

    Carbohydr. Res.

    (2012)
  • C. Chang et al.

    Molecular characterization of a plasmid isolated from Riemerella anatipestifer

    Avian Pathol.

    (1998)
  • R.M. Corrigan et al.

    Surface proteins that promote adherence of Staphylococcus aureus to human desquamated nasal epithelial cells

    BMC Microbiol.

    (2009)
  • A. Fomsgaard et al.

    Modification of the silver staining technique to detect lipopolysaccharide in polyacrylamide gels

    J. Clin. Microbiol.

    (1990)
  • X.-X. Gu et al.

    Synthesis and characterization of lipooligosaccharide-based conjugates as vaccine candidates for Moraxella (Branhamella) catarrhalis

    Infect. Immun.

    (1998)
  • A. Hamilton et al.

    Mutation of the maturase lipoprotein attenuates the virulence of Streptococcus equi to a greater extent than does loss of general lipoprotein lipidation

    Infect. Immun.

    (2006)
  • X. Han et al.

    Identification and immunological characteristics of chaperonin GroEL in Riemerella anatipestifer

    Appl. Microbiol. Biotechnol.

    (2012)
  • S. Khandavilli et al.

    Maturation of Streptococcus pneumoniae lipoproteins by a type II signal peptidase is required for ABC transporter function and full virulence

    Mol. Microbiol.

    (2008)
  • Cited by (18)

    • Evaluation of the immunoprotection efficacy of Riemerella anatipestifer fur-deficient mutant as an attenuated vaccine

      2023, Poultry Science
      Citation Excerpt :

      Precise prevention and control of RA may be achieved through the development of live bacterial vaccines. In recent years, a large number of virulence factors of RA have been confirmed (Chang, et al., 1998; Crasta, et al., 2002; Hu, et al., 2018; Wang, et al., 2017; Zhao, et al., 2016; Zou, et al., 2015), and as such, an attenuated strain has the potential to be a vaccine. Furthermore, the mutation of global regulators may be preferable over single virulence factors for targeting live attenuated vaccines because global regulators control a cascade of genes that are related to bacterial virulence, which may improve safety and immunogenicity (Asensio, et al., 2008; Miller, et al., 1993; Zhao, et al., 2016).

    • Characterization of the Riemerella anatipestifer M949_RS00050 gene

      2020, Veterinary Microbiology
      Citation Excerpt :

      Interestingly, the result showed that LPS purified from the mutant strain CH3ΔM949_RS00050 had the same ladder-like pattern compared to the wild-type strain CH3. Furthermore, in our previous work, we demonstrate that several genes, including M949_RS07405, M949_RS01915, M949_RS07580 and M949_RS07630 were involved in regulating the genes mainly responsible for bacterial polysaccharide biosynthesis in R. anatipestifer CH3 (Dou et al., 2017; Zou et al., 2015a, b). Consequently, we investigated the variability of these gene expressions between the wild-type strain CH3 and the mutant strain CH3ΔM949_RS00050.

    • Identification of a gene in Riemerella anatipestifer CH-1 (B739-2187) that contributes to resistance to polymyxin B and evaluation of its mutant as a live attenuated vaccine

      2016, Microbial Pathogenesis
      Citation Excerpt :

      Because attenuated live vaccines can induce long-term immunity and confer good protection, these vaccines would be advantageous over vaccines based on the subunit or dead bacteria [9–11]. Several virulence factors, including outer membrane protein A (OmpA) [12], CAMP cohemolysin [13], VapD [14] and the putative genes associated with lipopolysaccharide (LPS) synthesis, have been identified [15,16], and some of these virulence factors were used to develop subunit or live attenuated vaccine candidates [15,16]. Global regulator genes may be preferable for live vaccine development over these single virulence factors because global regulators mediate and control a cascade of genes that are essential for bacterial virulence, and their mutation in vaccine development could improve the safety and immunogenicity of vaccines compared with single virulent gene-based vaccines [17,18].

    View all citing articles on Scopus
    View full text